A carregar...
Publicação
A strategic analysis of entry mode choices for Sanofi in the insulin market of Africa
| Nome: | Descrição: | Tamanho: | Formato: | |
|---|---|---|---|---|
| 3.54 MB | Adobe PDF |
Autores
Orientador(es)
Resumo(s)
This thesis examines the optimal market entry strategy for Sanofi's expansion into
the African insulin market. Grounded in a theoretical framework that identifies factors influencing
the choice of market entry mode, the study evaluates internal capabilities and external
conditions. Key findings suggest significant opportunities for Sanofi due to a largely untapped
market, strong internal capabilities, and a growing demand for insulin. Recommendations include
pursuing a greenfield venture in Kenya to establish production facilities in Africa. With
the support of the local government and international institutions, Sanofi can minimize operational
risks, reduce capital expenditures, and, ultimately, improve insulin accessibility across
Africa.
Descrição
Palavras-chave
Market entry mode Insulin access Africa Healthcare CEMS MIM